Phase II study of weekly Vinorelbine and Topotecan administration treatment for refractory adult rhabdomyosarcoma previously treated by VAC regimen.
Phase 1
Recruiting
- Conditions
- refractory adult rhabdomyosarcoma previously treated by VAC regimen.
- Registration Number
- JPRN-UMIN000005132
- Lead Sponsor
- ational Cancer Research Center Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 16
Inclusion Criteria
Not provided
Exclusion Criteria
1. No pregnant 2. No active infections 3. No interstitial pneumonia by X-ray 4. No symptom of brain metastais 5. No HIV positive 6. No grade 3 peripherasl neuropathy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response rate
- Secondary Outcome Measures
Name Time Method Adverse event Progression-free survival Overall survival